Barclays
CTVA icon

Barclays’s Corteva CTVA Stock Holding History

Barclays’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$113M Sell
1,353,187
-1,437,103
-52% -$108M 0.03% 452
2025
Q4 		$187M Buy
2,790,290
+847,620
+44% +$54.8M 0.04% 299
2025
Q3 		$131M Sell
1,942,670
-107,983
-5% -$7.83M 0.03% 406
2025
Q2 		$153M Buy
2,050,653
+481,664
+31% +$32.1M 0.04% 346
2025
Q1 		$98.7M Sell
1,568,989
-262,664
-14% -$16.2M 0.03% 424
2024
Q4 		$104M Sell
1,831,653
-270,108
-13% -$16M 0.03% 395
2024
Q3 		$124M Sell
2,101,761
-1,275,986
-38% -$69.7M 0.03% 368
2024
Q2 		$182M Buy
3,377,747
+840,991
+33% +$46.3M 0.06% 250
2024
Q1 		$146M Sell
2,536,756
-567,896
-18% -$29.3M 0.05% 294
2023
Q4 		$149M Buy
3,104,652
+474,225
+18% +$22.6M 0.05% 301
2023
Q3 		$135M Buy
2,630,427
+254,726
+11% +$13.5M 0.08% 237
2023
Q2 		$136M Buy
2,375,701
+1,000,400
+73% +$58.4M 0.09% 207
2023
Q1 		$82.9M Buy
1,375,301
+158,939
+13% +$9.71M 0.04% 300
2022
Q4 		$71.5M Buy
1,216,362
+308,622
+34% +$19.5M 0.03% 352
2022
Q3 		$51.9M Buy
907,740
+338,091
+59% +$19.7M 0.06% 304
2022
Q2 		$30.8M Sell
569,649
-172,788
-23% -$10M 0.02% 547
2022
Q1 		$42.7M Sell
742,437
-861,754
-54% -$44M 0.03% 462
2021
Q4 		$75.8M Buy
1,604,191
+186,899
+13% +$8.51M 0.03% 431
2021
Q3 		$59.6M Buy
1,417,292
+166,481
+13% +$7.2M 0.03% 456
2021
Q2 		$55.5M Buy
1,250,811
+249,595
+25% +$11.5M 0.03% 475
2021
Q1 		$46.7M Buy
1,001,216
+101,077
+11% +$4.47M 0.03% 474
2020
Q4 		$34.9M Sell
900,139
-824,091
-48% -$29.5M 0.02% 572
2020
Q3 		$49.7M Buy
1,724,230
+1,177,270
+215% +$33.1M 0.03% 399
2020
Q2 		$14.7M Sell
546,960
-861,893
-61% -$22.4M 0.01% 782
2020
Q1 		$33.1M Sell
1,408,853
-2,127,678
-60% -$58.5M 0.03% 447
2019
Q4 		$105M Buy
3,536,531
+1,030,341
+41% +$27.3M 0.06% 264
2019
Q3 		$70.2M Sell
2,506,190
-1,364,110
-35% -$39.4M 0.04% 344
2019
Q2 		$114M Buy
+3,870,300
New +$104M 0.07% 226

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Barclays's CTVA Position: Q1 2026 in Review

Barclays reduced its Corteva (CTVA) stake by 52% in Q1 2026, selling an estimated $108M and leaving 1,353,187 shares worth $113M. The position accounts for 0.03% of the portfolio, ranked #452.

Barclays first reported a position in CTVA in Q2 2019 and has held it in 28 quarters since. The position peaked at $187M in Q4 2025. 1,480 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

  • Barclays held 1,353,187 shares of Corteva worth $113M as of Q1 2026.
  • Barclays sold 1,437,103 Corteva shares in Q1 2026, an estimated $108M.
  • Corteva made up 0.03% of Barclays's portfolio in Q1 2026, its #452 holding.
  • Barclays first reported a position in Corteva in Q2 2019 and has held it in 28 quarters since.
  • Barclays's Corteva position peaked at $187M in Q4 2025.
  • 1,480 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.